首页> 外国专利> SUBSTITUTED 2-PYRIMIDINYL-6,7,8,9-TETRAHYDROPYRIMIDO(1,2-A)PYRIMIDIN-4-ONE AND 7-PYRIMIDINYL-2,3-DIHYDROIMIDAZO(1,2-A)PYRIMIDIN-5(1H)ONE DERIVATIVES FOR NEURODEGENERATIVE DISORDERS

SUBSTITUTED 2-PYRIMIDINYL-6,7,8,9-TETRAHYDROPYRIMIDO(1,2-A)PYRIMIDIN-4-ONE AND 7-PYRIMIDINYL-2,3-DIHYDROIMIDAZO(1,2-A)PYRIMIDIN-5(1H)ONE DERIVATIVES FOR NEURODEGENERATIVE DISORDERS

机译:取代了2-PYRIMIDINYL-6,7,8,9-TETRAHYDROPYRIMIDO(1,2-A)PYRIMIDIN-4-ONE和7-PYRIMIDINYL-2,3-DIHYDROIMIDAZO(1,2-A)PYRIMIDIN-5(1H)ONE神经退行性疾病的衍生物

摘要

The invention relates to use of a pyrimidone derivative represented by formula (I) or a salt thereof as therapeutic agents: Wherein m, n, p, X, Y, R1, R2, R3, R4 R5, are as defined herein. The invention specifically relates to a medicament comprising the said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a neurodegenerative disease caused by abnormal activity of GSK3 or GSK3 and cdk5/p25, such as Alzheimer disease.
机译:本发明涉及式(I)代表的嘧啶酮衍生物或其盐作为治疗剂的用途:其中,m,n,p,X,Y,R 1,R 2,R 3,R 4 R 5如本文所定义。本发明具体涉及包含所述衍生物或其盐作为有效成分的药物,该药物用于预防和/或治疗由GSK3或GSK3和cdk5 / p25的异常活性引起的神经退行性疾病,例如阿尔茨海默氏病。 。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号